Active Ingredient(s):Nesiritide, BNP FDA Approved: * August 10, 2001 Pharm Company: *SCIOS Category:Blood Vessels
Nesiritide (Natrecor) is the recombinant form of the 32 amino acid human B-type natriuretic peptide, which is normally produced by the ventricular myocardium. Nesiritide works to facilitate cardiovascular fluid homeostasis through counterregulation of the renin–angiotensin–aldosterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation.
Nesiritide was believed initially to be beneficial for acute decompensated congestive heart failure. It r...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion
Natrecor 1.5 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution